GotoPER - Physicians' Education Resource
Back to Home
Video

Tumor Board: Clinical Integration of Molecular Profiling in Glioma—Transforming the Use of Targeted Therapy

Create AccountAlready Registered? Login Here

Release Date

April 28, 2026

Expiration Date

June 3, 2026

Credits

1.5 CME, NCPD

Activity Overview

This educational activity is an archive of the live presentation held on April 20, 2026.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is directed toward physicians, nurses, nurse practitioners, physician assistants, and other health care providers involved in the management of gliomas.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Integrate current classification criteria and diagnostic strategies for identifying adult and pediatric patients with glioma
  • Incorporate genetic and molecular information to classify gliomas and develop personalized treatment plans accurately
  • Evaluate the data for recent advancements in targeted agents, immunotherapies, and other innovative treatment methods for treating patients with gliomas
  • Identify strategies to integrate targeted therapies, immunotherapies, and novel emerging treatment approaches for managing pediatric patients with gliomas.
Tumor Board: Clinical Integration of Molecular Profiling in Glioma—Transforming the Use of Targeted Therapy

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education ResourceL®, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Jazz Pharmaceuticals.

Follow Us on Social Media!

You Also Might Like...

Tumor Board: Clinical Integration of Molecular Profiling in Glioma—Transforming the Use of Targeted TherapyFree CE/CME

Tumor Board: Clinical Integration of Molecular Profiling in Glioma—Transforming the Use of Targeted Therapy

Cure to Cancer Survivorship: A New Era of Biomarkers, Interventions, and Care ModelsLive Event

Cure to Cancer Survivorship: A New Era of Biomarkers, Interventions, and Care Models

Oncology Town Hall: From Evidence to Action—Applying KRAS-Targeted Advances in Solid TumorsVirtual Event

Oncology Town Hall: From Evidence to Action—Applying KRAS-Targeted Advances in Solid Tumors

PER Global Perspectives: Preparing for the Emergence of TROP2 ADCs With Immunotherapy in the Earlier Treatment SettingsFree CE/CME

PER Global Perspectives: Preparing for the Emergence of TROP2 ADCs With Immunotherapy in the Earlier Treatment Settings

Course

Tumor Board: Clinical Integration of Molecular Profiling in Glioma—Transforming the Use of Targeted Therapy

Create Account